Dr. Stephen J. Di Martino specializes in the treatment of myositis, rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and osteoarthritis. He is actively involved in clinical research on myositis treatment and serves as the Medical Advisor to the Hospital for Special Surgery Myositis Support Group. Dr. Di Martino completed his fellowship in Rheumatology at HSS, and is board certified in Internal Medicine and Rheumatology.
Assistant Attending Rheumatologist, Hospital for Special Surgery
Instructor in Clinical Medicine, Weill Cornell Medical College
Systemic lupus erythematosus
American College of Rheumatology
Hospital for Special Surgery Myositis Support Group - Medical Advisor
MD/PhD, State Univertisty of New York at Stony Brook School of Medicine, 1999
New York Presbyterian Hospital, Cornell Campus, 1999-2000
New York Presbyterian Hospital, Cornell Campus, 2000-2001
Hospital for Special Surgery, 2001-2005
Internal Medicine, 2002
Stephen J. Di Martino, MD, PhD has contributed to the following articles on HSS.edu:
Di Martino, SJ. Idiopathic Inflammatory Myopathy: Treatment Options. Current Rheumatology Reports 10(4):321-7, 2008.
Di Martino, SJ. Stronger Decision Making in Myositis. Journal of Musculoskeletal Medicine, 2008.
Di Martino, SJ; Yuan, W; Redecha, P; Ivashkiv, LB; Salmon, JE. Insoluble Immune Complexes are Most Effective at Triggering IL-10 Production in Human Monocytes and Synergize with TLR Ligands and C5a. Clinical Immunology 127(1):56-65, 2008.
Di Martino, SJ; Trujillo, G; McVoy, LA; Kew, RR. Upregulation of Vitamin D Binding Protein (Gc-Globulin) Binding Sites During Neutrophil Activation from a Latent Reservoir in Azurophil Granules. Molecular Immunology 44(9):2370, 2007.
Di Martino, SJ; Kagen, LJ. Newer Therapeutic Approaches: Inflammatory Muscle Disorders. Rheumatic Disease Clinics of North America 32: 121, 2006.
Shah, AB; Di Martino, SJ; Trujillo G; Kew, RR. Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3. Molecular Immunology 43(8):1109-15, 2006.
Di Martino, SJ; Paget, SA. On the Importance of Early Arthritis Centers. HSS Journal 1:107, 2005.
For more publications, please see the PubMed listing
Di Martino, SJ and Ivashkiv, LB. Therapeutic targets for the treatment of autoimmune disease. In: Yee, A, Paget, SA, editors. Expert Guide to Rheumatology
. Philadelphia; American College of Physicians, 2004.
Dr. Di Martino is involved with the following clinical trials.
RIM: Rituximab in the treatment of Myositis, Chester Oddis, MD; Ann Reed, MD
Site principle investigator: To determine the effects of rituximab in refractory polymyositis and dermatomyositis
RAVE: Rituximab for ANCA-associated Vasculitis, Robert Spiera, MD (site PI)
Site co-investigator: To determine the effect of rituximab on remission induction in patient with ANCA-associated vasculitis